Topical hemostatic agents in gynecologic surgery

Obstetrical and Gynecological Survey

Volumn 63, Issue 6, 2008, Pages 389-394

  Duenas Garcia, Omar Felipe ^a   Goldberg, Jeffrey M ^b  

^a INSTITUTO NACIONAL DE PERINATOLOGÍA   (Mexico)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ARGIPRESSIN; BUPIVACAINE; COLLAGEN; FIBRIN GLUE; GELATIN SPONGE; HEMOSTATIC AGENT; HEPARIN; MICROCRYSTALLINE COLLAGEN; MISOPROSTOL; OXIDIZED REGENERATED CELLULOSE; OXYTOCIN; PROTHROMBIN; THROMBIN; VASOPRESSIN; WARFARIN; FIBRIN; GELATIN; OXIDIZED CELLULOSE; VASOPRESSIN DERIVATIVE;

ABDOMINAL HYSTERECTOMY; BLEEDING; BLOOD PRESSURE; CLINICAL TRIAL; DRUG SUBSTITUTION; GYNECOLOGIC SURGERY; HEART INFARCTION; HEART RATE; HUMAN; HYPERTENSIVE CRISIS; LUNG EDEMA; MYOMECTOMY; OVARIECTOMY; PEROPERATIVE COMPLICATION; REVIEW; RISK BENEFIT ANALYSIS; SALPINGECTOMY; SIDE EFFECT; VAGINAL HYSTERECTOMY; HEMOSTASIS;

CELLULOSE, OXIDIZED; FIBRIN; GELATIN; GYNECOLOGIC SURGICAL PROCEDURES; HEMOSTASIS, SURGICAL; HEMOSTATICS; HUMANS; THROMBIN; VASOPRESSINS;

EID: 54749153684     PISSN: 00297828     EISSN: 15339866     Source Type: Journal    
DOI: 10.1097/OGX.0b013e31816ff805     Document Type: Review

References (37)

1. Tan TC, Black PM. Sir Victor Horsley (1857-1916): pioneer of neurological surgery. Neurosurgery 2002;50:607-611 ; discussion 611-612.
2. Hong YM, Loughlin KR. The use of hemostatic agents and sealants in urology. J Urol 2006;176:2367-2374.
3. Stone JL. Sir Charles Ballance: pioneer British neurological surgeon. Neurosurgery 1999;44:610-631; discussion 631-632.
4. Tomizawa Y. Clinical benefits and risk analysis of topical hemostats: a review. J Artif Organs 2005;8:137-142.
5. Mannucci PM. Hemostatic drugs. N Engl J Med 1998;339: 245-253.
6. Spangler D, Rothenburger S, Nguyen K, Jampani H, Weiss S, Bhende S. In vitro antimicrobial activity of oxidized regenerated cellulose against antibiotic-resistant microorganisms. Surg Infect (Larchmt) 2003;4:255-262.
7. Wiseman DM, Kamp LF, Saferstein L, et al. Improving the efficacy of INTERCEED Barrier in the presence of blood using thrombin, heparin or a blood insensitive barrier, modified INTERCEED (nTC7). Prog Clin Biol Res 1993;381:205-212.
8. 8. Larsson B, Nisell H, Granberg I. Surgicel-an absorbable hemostatic material-in prevention of peritoneal adhesions in rats. Acta Chir Scand 1978;144:375-378. (Pubitemid 9114617)
9. 9. Sharma JB, Malhotra M, Pundir P. Laparoscopic oxidized cellulose (Surgicel) application for small uterine perforations. Int J Gynaecol Obstet 2003;83:271-275. (Pubitemid 37468431)
10. 10. Sharma JB, Malhotra M. Topical oxidized cellulose for tubal hemorrhage hemostasis during laparoscopic sterilization. Int J Gynaecol Obstet 2003;82:221-222. (Pubitemid 36842851)
11. Kitamura K, Yasuoka R, Ohara M, et al. How safe are the xenogeneic hemostats? -Report of a case of severe systemic allergic reaction. Surg Today 1995;25:433-435.
12. Nakajima M, Kamei T, Tomimatu K, et al. An intraperitoneal tumorous mass caused by granulomas of microfibrillar collagen hemostat (Avitene). Arch Pathol Lab Med 1995;119:1161-1163.
13. 13. Borten M, Friedman EA. Translaparoscopic hemostasis with microfibrillar collagen in lieu of laparotomy. A report of two cases. J Reprod Med 1983;28:804-806. (Pubitemid 14211264)
14. Holub Z, Jabor A. Laparoscopic management of bleeding after laparoscopic or vaginal hysterectomy. J Soc Laparosc Surg 2004;8:235-238.
15. Rousou J, Levitsky S, Gonzalez-Lavin L, et al. Randomized clinical trial of fibrin sealant in patients undergoing resternotomy or reoperation after cardiac operations. A multicenter study. J Thorac Cardiovasc Surg 1989;97:194-203.
16. Schoenecker JG, Johnson RK, Fields RC, et al. Relative purity of thrombin-based hemostatic agents used in surgery. J Am Coll Surg 2003;197:580-590.
17. Lawson JH. The clinical use and immunologic impact of thrombin in surgery. Seminin Thromb Hemost 2006;32(suppl 1):98-110.
18. Ortel TL, Mercer MC, Thames EH, Moore KD, Lawson JH. Immunologic impact and clinical outcomes after surgical exposure to bovine thrombin. Ann Surg 2001 ;233:88-96.
19. 19. Adams JD, Jones S, Brost BC. Development of antibodies to topical bovine thrombin after abdominal hysterectomy. A case report. J Reprod Med 2001;46:909-912. (Pubitemid 33032052)
20. Baumann G, Dingman JF. Distribution, blood transport, and degradation of antidiuretic hormone in man. J Clin Invest 1976;57:1109-1116.
21. 21. Heilborn H, Hjemdahl P, Daleskog M, et al. Comparison of subcutaneous injection and high-dose inhalation of epinephrineimplications for self-treatment to prevent anaphylaxis. J Allergy Clin Immunol 1986;78:1174-1179. (Pubitemid 17227464)
22. 22. Tulandi T, Beique F, Kimia M. Pulmonary edema: a complication of local injection of vasopressin at laparoscopy. Fertil Steril 1996;66:478-480. (Pubitemid 27009894)
23. Corson SL, Brooks PG, Serden SP, et al. Effects of vasopressin administration during hysteroscopic surgery. J Reprod Med 1994;39:419-423.
24. Keckstein J, Karageorgieva E, Darwish A, et al. Laparoscopic Myomectomy: Sonographic Follow-Up and Second-Look Laparoscopy for the Evaluation of a New Technique. J Am Assoc Gynecol Laparosc 1994;1:S16.
25. 25. Fletcher H, Frederick J, Hardie M, et al. A randomized comparison of vasopressin and tourniquet as hemostatic agents during myomectomy. Obstet Gynecol 1996;87:1014-1018. (Pubitemid 26159402)
26. Crawford JT EA, Pereira L, Bednarek P, Buckmaster J. The effects of vasopressin injection on uterine artery blood flow during dilation and evacuation. Am J Obstet Gynecol 2007; 196:e38-e39.
27. Phillips DR, Nathanson HG, Milim SJ, et al. The effect of dilute vasopressin solution on blood loss during operative hysteroscopy: a randomized controlled trial. Obstet Gynecol 1996;88: 761-766.
28. Munoz JL, Jimenez JS, Hernandez C, et al. Hysteroscopic myomectomy: our experience and review. Jsls 2003;7:39-48.
29. Okin CR, Guido RS, Meyn LA, et al. Vasopressin during abdominal hysterectomy: a randomized controlled trial. Obstet Gynecol 2001;97:867-872.
30. Kongnyuy EJ, Wiysonge CS. Interventions to reduce haemor- rhage during myomectomy for fibroids. Cochrane Database Syst Rev 2007:CD005355.
31. Weaver FA, Hood DB, Zatina M, et al. Gelatin-thrombin-based hemostatic sealant for intraoperative bleeding in vascular surgery. Ann Vase Surg 2002;16:286-293.
32. 32. Vezeau PJ. Dental extraction wound management: medicating postextraction sockets. J Oral Maxillofac Surg 2000;58:531-537 (Pubitemid 30246408)
33. Valtonen EJ. Observations on the formation of intraabdominal and subcutaneous adhesions due to the use of surgical gelatin sponge. Acta Chir Scand 1966;131:107-211.
34. Sciscione AC, Manley JS, Pollock M, et al. Intracervical fibrin sealants: a potential treatment for early preterm premature rupture of the membranes. Am J Obstet Gynecol 2001; 184: 368-373.
35. Cortes RA, Wagner AJ, Lee H, et al. Pre-emptive placement of a presealant for amniotic access. Am J Obstet Gynecol 2005; 193:1197-1203.
36. Palacios Jaraquemada JM, Pesaresi M, Nassif JC, et al. Anterior placenta percreta: surgical approach, hemostasis and uterine repair. Acta Obstet Gynecol Scand 2004;83: 738-744. (Pubitemid 39062148)
37. Neilson JP. Interventions to reduce haemorrhage during myomectomy for fibroids. Obstet Gynecol 2007;109:1197-1198.